Related by context. All words. (Click for frequent words.) 72 License Agreement 68 Licensing Agreement 65 License Agreements 63 License Option Agreement 63 Collaboration Agreement 63 Distribution Agreement 62 Transfer Agreement 61 Licence Agreements 61 Patent License Agreement 61 Supply Agreement 60 Agreement 59 Master License Agreement 59 Acquisition Agreement 59 Distributorship Agreement 58 Commercialization Agreement 58 Assignment Agreement 57 Reseller Agreement 57 Sublicense Agreement 57 Confidentiality Agreement 57 Representation Agreement 57 Amended Agreement 57 License Pact 57 Tenancy Agreement 57 Termination Agreement 57 Exclusivity Agreement 57 Joint Venture Agreement 57 Supply Agreements 56 Purchase Agreement 56 Distribution Agreements 56 Cooperation Agreement 56 Sponsorship Agreement 56 Distributor Agreement 55 Licensing Agreements 55 Transfer Agreements 55 Agreements 55 Amending Agreement 54 Binding Agreement 54 Cooperation Agreements 54 Loan Agreement 54 Teaming Agreement 54 Lease Agreement 54 Licensing Deal 54 Cross License Agreement 53 Financing Agreements 53 Exclusive License 53 Cross Licensing Agreement 53 Definitive Agreements 53 Announce Licensing 52 Abbotly 52 Lease Agreements 52 Implementation Agreement 52 Implementation Deed 52 Misonix Announces 52 MOU 52 Tenancy Agreements 52 Enters Into Joint Venture 52 Ongoing Connected Transactions 52 Definitive Agreement 52 Combination Agreement 52 Purchase Agreement dated 52 Waiver Agreement 52 Affiliation Agreement 52 Option Deed 52 Commencement Date 52 Joint Venture Agreement JVA 51 Partnership Agreement 51 Licensing Pact 51 Exclusivity 51 Share Purchase Agreement 51 Trademark License Agreement 51 Secures Patent 51 WSPP 51 PolyNovo 51 Joint Venture Agreements 51 Asset Purchase Agreement 51 discloseable transaction 51 Subsidiary Enters 51 Signs Licensing 51 Worldwide Licensing Agreement 51 Enters Into Definitive 51 Option Agreement 51 Modem Card 51 sublicense 51 Participation Agreement 50 Patent Infringement Litigation 50 LOI 50 Framework Agreements 50 Secures Exclusive 50 Early Termination 50 Escrow Agreement 50 Exclusive License Agreement 50 Purchase Agreement SPA 50 Signs Licensing Agreement 50 Option Agreements 50 Interconnection Agreement 50 Definitive Option Agreement 50 Standstill Agreement 50 Purchase Agreements 50 Enters Into Licensing Agreement 50 Agreement SEDA 50 Levucell 50 Franchise Agreements 50 Reverse Takeover 50 Arrangement MFA 50 binding Letter 50 Formal Agreement 50 Exclusive Licensing Agreement 50 Polysilicon Supply Agreement 50 Enters Into Long Term 50 Sublicense 50 suspensive condition 50 Letter Agreement 50 Arbitration Proceeding 50 License Application 50 Definitive Purchase Agreement 50 Signs Definitive 50 Framework Agreement 50 Resolves Dispute 50 Offtake Agreement 50 Distribution Pact 50 Purchase Option Agreement 49 GMP Certificate 49 Settles Litigation 49 farmin agreement 49 Hereinafter 49 Licences 49 YTE 49 Formal Option Agreement 49 DIP Loan 49 Settle Litigation 49 Amends Agreement 49 Tolling Agreement 49 Licencing 49 Sign License Agreement 49 Milestone Payments 49 Amalgamation Agreement 49 Multimillion Dollar Contract 49 Farmout 49 Compulsory License 49 Acacia Subsidiary 49 Royalty Payments 49 MoU 49 Binding Letter 49 sublicenses 49 CollaRx GENTAMICIN SURGICAL IMPLANT 49 Subscription Agreement 49 sublicensee 49 Marketing Authorisation 49 AIMMS 49 Revolutionises 49 Definitive Merger Agreement 49 Exclusivity Period 49 ICANN Approves 49 Settles Patent Litigation 49 Authorisations 49 Confidentiality Agreements 49 Concession Agreement 49 BioSyent Pharma 49 Protection Agreement BIPPA 48 agreement 48 Patent Licensing Agreement 48 Terminate Agreement 48 Clearford Announces 48 Enter Into Definitive 48 Complementarity 48 Cooperation Framework Agreement 48 Acqusition 48 Contribution Agreement 48 Derma Sciences Announces 48 BioSante Pharmaceuticals Announces 48 Non Binding Letter 48 InterfeRx 48 Consent Judgment 48 Exclusive Distribution 48 Acquisition Proposal 48 Pennsaid R 48 Signs License Agreement 48 Announces License Agreement 48 Announce Licensing Agreement 48 Renews Multi 48 SecuTech 48 Formal Agreements 48 Private Placement Closed 48 Announces Licensing Agreement 48 Completes Asset 48 Miraculins Announces 48 Confirms Commitment 48 Agree ment 48 Outsourcing Contract 48 Value Added Reseller Agreement 48 Permanent Injunction Against 48 TRIPs Agreement 48 Files Patent Application 48 Asset Swap 48 Signs Multiyear 48 Exclusive Licensee 48 Antibody Discovery 48 Zor Pharmaceuticals 48 Therapeutic Competitors Report 48 theagreement 48 Patents Issued 48 BioElectronics Corporation Announces 48 Licence 48 Execute Definitive 48 Signs Binding 47 Stock Purchase Agreements 47 Subscription Agreements 47 Subsidiary Enters Into 47 Commitment Letter 47 OFCD Optionally Fully 47 Definitive Acquisition 47 Patent Dispute 47 Amended Option Agreement 47 Non Infringement 47 LoI 47 Obtains License 47 Sign Licensing Agreement 47 Permanent Injunction 47 Enters Into Exclusive 47 Tripartite Agreement 47 Merger Transaction 47 Forbearance Agreement 47 Enters Beta 47 Amend Merger Agreement 47 Clause #.#.# 47 Legal #.# 47 Term Sheet 47 Xing Yang Security 47 Renews Exclusive 47 Asiainfo 47 TVI Subscription Agreement 47 Intellectual Property Rights TRIPs 47 TRIPS Agreement 47 Completes Reverse Merger 47 NQCI 47 Global FranTech 47 License Agreement EULA 47 Announce Commencement 47 Nippon Shinyaku 47 Terminates Agreement 47 Exclusive Distributorship 47 Cease Trade Orders 47 Conditional Approval 47 Shareholders Approve Proposed 47 Inks License 47 Patent Infringement Case 47 Settlement Agreement Regarding 47 Jacada Signs 47 notarial deed 47 Signs Joint Venture 47 Medicure Announces 47 Obtains Exclusive 47 Enters Strategic 47 Recapitalization Transaction 47 Settlement Agreement 47 Conditions Precedent 47 Extend Collaboration 47 Loramyc ™ 47 Compulsory Licensing 47 parties hereto 47 Begins Shipment 47 Debt Settlement Agreements 47 Implantable Medical 47 Extend Partnership 47 Announce Successful Completion 47 Patent Covering 46 Registered Trademarks 46 licensing agreements 46 Current Merger Agreement 46 Modification Agreement 46 Underwriting Agreement 46 DFAR #.#-# 46 Standby Commitment 46 binding LOI 46 Extends Term 46 TOP Ships Announces 46 Manufacturer Warranty 46 Settlement Agreements 46 BugOil R 46 Wafer Supply 46 Original Bidder Statement 46 Concession Agreements 46 Intellectual Property Portfolio 46 ASX Listing 46 Milestone Payment 46 Diamyd Medical Diamyd 46 WebTech Wireless Announces 46 Flamel Technologies Announces 46 Patent Upheld 46 Signs Agreements 46 Conversion Date 46 Transferee 46 Inks Licensing Deal 46 Exclusive Licensing 46 agreements 46 GRAS Status 46 EPC Contract 46 SES ASTRA Signs 46 Agreement CPA 46 Enters Into LOI 46 HSR Waiting Period 46 Extends Collaboration 46 Globetech 46 Completion Date 46 Seikagaku Corporation 46 Patent Portfolios 46 CCI Pellet Agreements 46 exclusive distributorship 46 Orgaman 46 Fanotech 46 UnixWare #.#.# 46 Purchased Assets 46 Proposed Arrangement 46 Engages CHF Investor Relations 46 Amends Revolving Credit 46 Exploitation Concession 46 Non Exempt 46 Enters Into Strategic 46 Royalty Rates 46 Not Disclosed 46 License Fees 46 Proposed Takeover 46 ZTEST Announces 46 Leases 46 MSc Qualified Person 46 Mining Leases 46 Stipulated 46 agreementwith 46 Previously Announced Private Placement 46 Terminates Letter 46 Purchaser shall 46 PTY Ltd. 46 Offerors Commercial applies 46 Collective Agreements 46 Urocidin TM 46 Fulun Steel 46 Licenses Patents 46 Osiris retains 46 Stock Purchase Agreement 46 BQT 46 Accession Agreement 46 Announces Definitive Merger 46 GPSi Asia 46 Reseller Partnership 46 FY# Loss Narrows 46 Signs Option Agreement 46 Signs Merger Agreement 46 No. RE# [001] 46 Briyante 46 WTO TRIPS Agreement 46 CMDCAS 46 Registered Trademark 46 Due Diligence Period 46 Panta Holdings 46 Thin Film Solar Modules 46 Rights TRIPS 46 Recordable Media 46 Orphan Designation 46 MBMI Closes 46 blutip Power 46 HHSN#C 46 Stockholder Rights Agreement 45 Protection Agreement BIPA 45 No. #.# 45 POTELLIGENT R Technology 45 Achieves Milestone 45 Securities Purchase Agreement 45 Daiichi Suntory Pharma 45 Enters Into Partnership 45 #,#,# warrants exercisable 45 Wholly owned Subsidiary 45 Exploration Permit Application 45 Production Sharing Agreement EPSA 45 Obtains Exclusive Rights 45 Inks Supply 45 Receives CE Marking 45 Termination Notice 45 TM MMP Portfolio 45 #.#-# Offeror Representations 45 Terminates Merger Agreement 45 Entered Into 45 Strategic Alliance 45 Milestone Payment From 45 Director Shareholding 45 Announces Definitive Agreement 45 transactions contemplated thereunder 45 tripartite MoU 45 Inks Exclusive 45 Placing Agreement 45 DVD Copying 45 Platform Enables 45 charterparty 45 resolves patent infringement 45 Lupin Pharmaceuticals 45 Seamless Integration 45 farmout agreement 45 Ark. Sup 45 Farmout Agreement 45 Turnkey Contract 45 Agreement HoA 45 Infringing 45 InStorage REIT Announces 45 Awarded GSA 45 OPENLiMiT 45 Million Pounds Sterling 45 Enters Into License Agreement 45 Secured Loan 45 Finalises 45 Decision #-# 45 REGPARA 45 Offset Obligation 45 Concurrent Financing 45 Settlement Stipulation 45 Patents Upheld 45 rolling Biologics License 45 FAR #.#-# Instructions 45 Contract Renewal 45 NanoTherapies 45 Announce License Agreement 45 Cooperation Treaty 45 Binding Offer 45 Circumvention 45 Helicos BioSciences Announces 45 Rollover Amount 45 Summary Judgement 45 Regulatory Approvals 45 obligations hereunder 45 Preferential Allotment 45 Secured Debenture 45 FY# Loss Widens 45 Procedural Rules 45 Connected Device 45 PROCAPS 45 Announces Revocation 45 Arbitration Proceedings 45 Extend Relationship 45 Underlying Option Agreement 45 sublicensing agreements 45 Licensing Fees 45 Issues Shareholder 45 Executes Agreement 45 Option Grants 45 Enters Option Agreement 45 Farmin Agreement 45 PDS PDS 45 NMP# ® 45 Seasonal Influenza Vaccine 45 Continuing Connected Transactions 45 VNUS patents 45 Holdings Proprietary Limited 45 des Mines Gecamines 45 Anti Dumping Duty 45 PTY Ltd 45 Use Thereof 45 Anti CD# Antibody 45 License Agreement SPLA 45 Nutra Pharma Announces 45 Irrevocable Undertakings 45 Emission Reduction Purchase Agreement 45 DOE USEC 45 Whitewash Waiver 45 Announce Definitive Merger 45 Issued Patent 45 Property Option Agreement 45 Completes Financing 45 Acquire Controlling Stake 45 Nasdaq Delisting Notice 45 validly terminated 45 Stock Buyback Program 45 Achieves Significant 45 Expands Scope 45 Enabling Clause 45 Signs MOU 45 CIP TRAMADOL ER 45 Prospecting License 45 Jointly Announce 45 Nanophase Announces 45 Continuing Connected Transaction 45 Commences Subsequent 45 Announce Exclusive 45 Completes Reorganization 45 Citycon Oyj 45 Joint Venture JV 45 Tostrex 45 No. HHSN#C 45 exclusive licensor 45 Inks Distribution 45 Announce Merger Agreement 45 Antitrust Settlement 45 Patent Infringement Suit 45 MEDIA LIMITED 45 H1 Profit Rises 45 Enters Joint Venture 45 Transaction 45 HoA 45 Bypass Vulnerability 45 Successfully Integrates 45 Acquire Majority Stake 45 Signs MoU 45 Receives Funding 45 Replacement Prospectus 44 sub licensable 44 Officially Launched 44 Announce Shareholder Approval 44 Licensor 44 Fancamp Announces 44 Signs Non Binding 44 Successfully Launches 44 Licenses 44 Secured Debentures 44 Transferor Company 44 Acquires Controlling Interest 44 Tessera Licenses 44 Closes Financing 44 NFLPA Collective Bargaining 44 Elektrobit Corporation 44 Executes Letter 44 OTCBB YCKM 44 Taiho Pharmaceutical 44 EN NEO 44 Enters Into Multi 44 Mining License 44 Mutually Agree 44 Gets Clearance 44 Subsidiary Signs 44 Participation Agreements 44 www.3dsyndication.com 44 § #-#-# [002] 44 MMX Mineração e Metálicos 44 Listing Rule #.#.# [003] 44 Announce Interoperability 44 POTELLIGENT R 44 Scantek 44 Gentamicin Surgical Implant 44 Material Definitive Agreement 44 mutually terminated 44 Veregen R 44 Enters Into Letter 44 Commence Production 44 accredited registrar 44 Receives Approval From 44 Bilateral Agreements 44 Achieves ISO # 44 #.#-# Instructions 44 Forms Joint Venture 44 Pact 44 Amends Terms 44 PRC Accounting Standards 44 MOSAID patents 44 Exclusive Supplier 44 Enforcement Directive 44 Japanese Encephalitis Vaccine 44 Borgakim 44 COP IDS 44 Voluntary Surrender 44 sprl 44 ZBx 44 PrimeXsys 44 Enters Into Definitive Agreement 44 Lease Termination 44 Infringement Case 44 Debt Conversion 44 Signs Binding Letter 44 CONTINUING CONNECTED TRANSACTIONS 44 Patent Infringement Lawsuit 44 Al Qarn Alam 44 Bargaining Agreement 44 Strategic Rationale 44 Emblaze VCON 44 Acquires Exclusive 44 NYSE Amex Listing 44 Agreement CEFTA 44 NASDAQ SAMAS 44 Share Repurchase Plan 44 FAR Clause #.#-# 44 Extends Closing Date 44 Plant Varieties 44 Significantly Enhances 44 Settles Dispute 44 Reacquires 44 Erdenetsogt 44 Obtains Approval 44 Receives Patent 44 Canexus Announces 44 Grünenthal GmbH 44 VirnetX patents 44 Cautionary Announcement 44 Enters Into Agreement 44 Loramyc TM 44 irrevocable perpetual 44 Miscellaneous #.#.# Release 44 Non Discriminatory 44 Refinances Debt 44 greement 44 SEBI Guidelines 44 Proposed Qualifying Transaction 44 License 44 Licensee 44 SmartSwitch Namibia 44 DIP Financing Facility 44 Master Reseller 44 Acquistion 44 licensee 44 Patent Portfolio 44 Enters Into Collaboration 44 Restructures Debt 44 Biometric Identity 44 Patent Reexamination 44 Emission Reductions 44 ActiveSync protocol 44 Becomes Authorized 44 Controlling Stake 44 Polarcus Limited 44 competitively procured pursuant 44 MarketResearch.com Announces 44 Monitoring Agreement EUMA 44 Arbitrary Code 44 Acquire Assets 44 WpHG mit dem Ziel 44 Antaria Limited 44 Pricing Supplement 44 Announce Early Termination 44 Finalize Joint Venture 44 QPSX 44 Unapproved Share 44 Completes Transaction 44 b#x# http:/#.#.#.#/fls.geo/PH #x# #.hyahrtzeit 44 Immersion TouchSense 44 Gamecorp 44 Note Receivable 44 Second Tranche 44 Signs Distribution 44 MCTO 44 FAST InStream TM 44 Strengthens Position 44 Announces Debt Settlement 44 CLTI 44 Sign Definitive Agreement 44 Aquires 44 ASX Listing Rule #.#A 44 Promissory 44 Stocking Distributor 44 Unveils Newest 44 DIP financing facility 44 MAIN FACTS 44 Terminate Merger 44 Further Validates 44 Thomson Reuters ONE HUG 44 Restated Agreement 44 Establish Joint Venture 44 Trademark Infringement 44 Enters Exclusive 44 Argatroban 44 Announces Proposed Acquisition 44 Obtains Patent 44 Gene Expression Analysis 44 Integer Overflow 44 Promulgation 44 CJV 44 Forays Into 44 Terminates Contract 44 Asset Sale 44 Pooling Agreement 44 Boosts Capacity 44 MR Civ 44 licencee 44 Commercializes 44 Corp. OTC SOPK 44 Files IND 44 Secured Promissory Note 44 Q Pasa 44 v#.#.# [003] 44 Authorized Generics 44 Files Patent 44 Global Reseller Agreement 44 Ucyclyd Pharma Inc. 44 Standby Equity Distribution 44 Receives Milestone Payment 44 Common Criteria Recognition 44 AMEX AKN today 44 BQT Satellites 44 Kyowa Kirin 44 Exploration Permit 44 Tariff Order 44 Each Broker Warrant 44 DFARS #.#-# 44 Elan Pharma 44 OFDM OFDMA 44 Integra LifeSciences Announces 44 Compulsory Acquisition 44 Signs LoI 44 Teijin Pharma 44 Accelerated Assessment 44 Area Safta 44 Oncolys 44 Pty. Limited 44 Inks Deals 44 Patent Licensing 44 Inks Pact 44 CryptoLogic subsidiary WagerLogic 44 Announces Immediate Availability 44 System VRB ESS 44 Certificates STC 44 Share Incentive Scheme 44 PIPE Financing 44 Enters Into Distribution 44 Promissory Note 44 Material Fact 44 Injunction Against 44 Cavitation Technologies 44 Cotonou Partnership 44 Listings Policy 44 Listing Rule #.#.# [005] 44 SVRX 44 Ethical Guidelines 43 Multiplies 43 Revolving Credit Agreement 43 Reexamination Certificate 43 Coolpad Communications 43 Middleware Solution 43 Treaty PCT 43 Fortifies 43 DPA countermeasures 43 Sign Definitive Merger 43 Driving Licence 43 Contract 43 Fixed Dose Combination 43 Infringing Products 43 Prospecting Licence 43 GlobeRanger iMotion 43 Justsystem 43 Marketing Authorizations 43 Photodisinfection System 43 Receives Certification 43 ZCI Offer 43 Earns Certification 43 Clarifies Status 43 APA Format 43 H1 Profit Declines 43 Hydrocarbon Exploration 43 Strengthens Relationship 43 InvaGen 43 Million Dollar Contract 43 Noncompete 43 Streamlines Operations 43 Escrow Release 43 Patent Lawsuit 43 Discreet Certified 43 Transitional Provisions 43 Reclamation Permit 43 Regulatory Regime 43 patent EP# 43 Executes Definitive 43 MultiMedia Gift Card 43 Testosterone Gel 43 DIAGNOS Announces 43 Ltd SGM 43 Joint Venture 43 Revocation Order 43 Jointly Launch 43 Signs Binding Agreement 43 Dendritic Nanotechnologies Inc. 43 Reconnaissance Permit 43 Receives SFDA Approval 43 Wins Injunction Against 43 Finalizes Agreement 43 Securities Purchase Agreements 43 Regains Nasdaq 43 Receivables Securitization 43 MGM MIRAGE Hospitality 43 Settle Patent Litigation 43 Seabed Logging 43 Articulation Agreement 43 Provides Clarification 43 Subsidiary 43 Obtains Extension 43 Doubles Capacity 43 Medigen 43 Oral Calcitonin 43 NASDAQ Deficiency Notice 43 Visual Voicemail patents 43 Inks LOI 43 Contrac 43 Secures Long Term 43 Digital Signatures 43 commercialize telaprevir 43 Approves Share Repurchase 43 Code Signing Certificates 43 Sublease 43 Photovoltaic Module 43 Acquisition 43 Initiates Clinical 43 Jointly Offer 43 Closes Private Placements 43 Patent Infringement Suit Against 43 Unimin Offer 43 SignatureOne 43 Bayer Yakuhin 43 Exploration Licences 43 NASDAQ Delisting 43 Inc. LATEST NEWS 43 Terminate Merger Agreement 43 Increlex TM 43 Regulations Governing 43 Color Additives 43 Zcom Networks Announces 43 Shlomi Palas CEO 43 Option Agreement whereby 43 Proposed Private Placement 43 Remium AB 43 TORs 43 Senju Pharmaceutical Co. 43 Achieves ISO #:# Certification [002] 43 '# Patents 43 PTE Ltd. 43 GRALISE 43 Settles Patent Dispute 43 China LotSynergy Holdings 43 Settle Patent Dispute 43 Partial Offer 43 Visa Facilitation 43 First Tranche 43 Caleco 43 Patent Infringement 43 circumstances shall irasia.com 43 Internalisation 43 Subsidiary Completes 43 Solteq Oyj 43 Aldara ® 43 Nasdaq Listing Requirements 43 Resetting Instalment 43 Incentive Warrants 43 Certified Partner Status 43 refusal ROFR 43 GungHo 43 suspensive conditions 43 Acacia Subsidiary Enters 43 Juvantia 43 Mandatory Conversion Conditions 43 Successfully Concludes 43 reacquires 43 Ninestar 43 Mining Licence 43 hereunder shall 43 Expanding Presence 43 Signs Framework Agreement 43 Shenyang Brilliance Power 43 High Growth Forecasted 43 Agreements FTA 43 Nears Launch 43 Settles Patent 43 SPRL 43 Ownership Structure 43 Successfully Passes 43 Default Announcement 43 Receives Confirmation 43 GlaxoSmithKline Biologicals SA 43 Transferable 43 Cooperation Agreement TDCA 43 Inc. PINKSHEETS RELM 43 Patents 43 Enforceability 43 Loses Appeal Against 43 Assured Shorthold Tenancy 43 Warrant Indenture 43 Procures 43 Installment Payment 43 Stockwire.com OTC 43 Software Simplifies 43 murraychass.com 43 Aspocomp Oy 43 Inter Governmental Agreement 43 Ticket Resale 43 Code# [001] 43 sublicensing 43 MFDA Rules #.#.# 43 Privilege Escalation 43 Submits Application 43 Overriding Royalty 43 Extends Expiry Date 43 s.# [001] 43 Whois Privacy 43 Section #AA [002] 43 Finders Warrants 43 promisee 43 Performance Incentive Plan 43 Graniz Mondal Inc. 43 JSPA 43 SpeBio joint venture 43 Handok Pharmaceuticals 43 Debenture Holder 43 WiNet System 43 Reduces Debt 43 Intellectual Property Rights TRIPS 43 Monetizes 43 Fast Track Status 43 Becomes Wholly Owned Subsidiary 43 Recombinant Protein 43 Patent Infringement Claim 43 Secured Loan Notes 43 Marketing Authorization 43 CyberTel 43 Sponda Oyj 43 Shortfall Offer 43 Security Bypass Vulnerability 43 Enters Negotiations 43 Consent Agreement 43 SulphCo Announces 43 Enters Into Settlement Agreement 43 Patents Covering 43 Mulgravian 43 3G Handset 43 Mod Chip 43 Disclosure Requirement 43 Stockholder Approval 43 des Carrieres et 43 specifi ed 43 BioGeneriX 43 Return NSR 43 Contingent Value Rights 43 Bengara II PSC 43 return royalty NSR 43 ASIQ 43 Merged JV Company 43 Revised LOI 43 Acacia Subsidiary Acquires 43 Secured Convertible Debenture 43 Ditem Explorations 43 Offerors Commercial 43 irrevocable undertaking 43 Further Cautionary Announcement 43 Expands Internationally 43 Oracea ® 43 AB OMXS BINV 43 Scheme Consideration 43 Dalian Liyang 43 PAION AG 43 Tablet Device 43 Receives ISO #:# [002] 43 Paragraph IV Certification 43 Directive #/#/EEC [002] 43 Scheme Effective Date 43 Controlled Deployment 43 Subscription Advantage 43 Highly Concentrated 43 Initiates Dosing 43 Broadens Product 43 Java Specification Participation 43 intellectualproperty 43 Uses Thereof 43 Clearance Certificate 43 Captisol ® 43 NMP# ® BladderChek 43 Offerors Commercial Items 43 Convertible Loan 43 Completes Previously Announced 43 Expands Functionality 43 convertible promissory note 43 Pharmachem Revised Offer 43 PrePaid 43 Protocol 43 irrevocable undertakings 43 Announces Spin Off 43 Option Schemes 43 Trust Deed 43 CIMYM 43 Deepens Commitment 43 Enters Into 43 Operatorship 43 Partial Revocation 43 Kuhnil 43 Share Instalment 43 Revised Proposal 43 Concludes Acquisition 43 Ironstone Partners 43 Daewoong 43 MZO 43 Warrants Exercised 43 Control VMready vNIC 43 Antidumping Duties 43 Forbearance Agreements 43 Proposed Amalgamation 43 Amlodipine Besylate Tablets 43 Area AFTA 43 Agreement MPSA 43 Announces Shareholder Approval 43 Unsolicited Proposal From 43 Taps Lobbyist 43 Contingent Consideration 43 Bupropion HCl ER 43 Official Licensee 43 Pty Limited 43 Zero Coupon Convertible Notes 43 Airtime Sales 43 Directors Dealings 43 Flagship Product 43 Logo Usage 43 Solicitation Statement 43 Subsidiary Wins